Clinical features and outcomes in adults with COVID-19 during the pre-Omicron and Omicron waves

被引:3
|
作者
Martinot, M. [1 ,4 ]
Schieber, A. [2 ]
Ongagna, J. C. [2 ]
Henric, A. [2 ]
Eyriey, M. [2 ]
Mohseni-Zadeh, M. [1 ]
Ion, C. [1 ]
Demesmay, K. [3 ]
Gravier, S. [1 ]
Kempf, C. [2 ]
机构
[1] Hop Civils Colmar, Infect Dis Dept, Colmar, France
[2] Hop Civils Colmar, Clin Res Dept, Colmar, France
[3] Hop Civils Colmar, Pharm Dept, Colmar, France
[4] Hop Civils Colmar, Infect Dis Dept, 39 Ave Liberte, F-68024 Colmar, France
来源
INFECTIOUS DISEASES NOW | 2024年 / 54卷 / 02期
关键词
COVID-19; SARS-CoV-2; variants; Outcome; Mortality; Nosocomial cases; TRANSMISSION; SARS-COV-2; HEALTH;
D O I
10.1016/j.idnow.2023.104833
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We conducted a single-center retrospective study to compare patient characteristics and death rates during the Omicron (O, December 01, 2021, to September 30, 2022) and pre-Omicron (PO, March 01, 1920, to October 31, 2021) periods.Patients and Methods: We retrospectively analyzed the data of 2932 patients (1242 (O) and 1690 (PO)) hospitalized (>24 h) with laboratory-confirmed COVID.Results: Compared to the PO period, O period patients were less frequently men, had a lower body mass index and fewer comorbidities except for immunosuppression and pregnancy. Nosocomial COVID-19 accounted for 18.2 % (O) and 15.4 % (PO) of cases (p = 0.05). Patient mortality rates during the O and PO periods were 11.0 % and 16.9 % (p < 0.001), respectively. Unvaccinated status (p < 0.001), existence of comorbidities, (p < 0.001) and high LDH value at baseline (p = 0.015), but not the period, were identified as factors likely to explain death.Conclusion: During the Omicron period, the inpatient death rate remained > 10 %, especially among unvaccinated and comorbid patients. Nosocomial cases were more frequent.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] COVID-19 in Older Adults at the Time of the Omicron Variant
    Gabrielli, Maurizio
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [32] Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants
    Exner, Hannah M.
    Gregorchuk, Branden S. J.
    Crisostomo, Leandro
    Kolsun, Kurt
    Giesbrecht, Shayna
    Dust, Kerry
    Alexander, David C.
    Bolaji, Ayooluwa
    Quill, Zoe
    Head, Breanne M.
    Meyers, Adrienne F. A.
    Sandstrom, Paul
    Becker, Michael G.
    MICROBIOLOGY SPECTRUM, 2024, 12 (07): : e0016324
  • [33] Concordance and generalization of an AI algorithm with real-world clinical data in the pre-omicron and omicron era
    Yilmaz, Gulsen
    Sezer, Sevilay
    Bastug, Aliye
    Singh, Vivek
    Gopalan, Raj
    Aydos, Omer
    Ozturk, Busra Yuce
    Gokcinar, Derya
    Kamen, Ali
    Gramz, Jamie
    Bodur, Hurrem
    Akbiyik, Filiz
    HELIYON, 2024, 10 (03)
  • [34] Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19
    Yek, Christina
    Kadri, Sameer S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (19): : 1977 - 1978
  • [35] Indirect effectiveness of COVID-19 vaccines in the pre-omicron and omicron periods: A nation-wide test-negative case-control study in Brazil
    Cerqueira-Silva, Thiago
    Boaventura, Viviane S.
    Pearce, Neil
    Barral-Netto, Manoel
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 148
  • [36] Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial (Withdrawn Publication)
    Lacout, Alexis
    Azalbert, Xavier
    Reverbel, Corinne
    Lesgards, Jean-Francois
    Cerdan, Dominique
    Lounnas, Valere
    Guillaume, Gerard
    Zizi, Martin
    Perronne, Christian
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024,
  • [37] Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-omicron or omicron variants: a modelling analysis of the randomized DisCoVeRy trial-authors' response
    Beaulieu, Maxime
    Guedj, Jeremie
    DisCoVeRy Study Group
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025, 80 (03) : 892 - 893
  • [38] Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era
    Lee, Chan Mi
    Kim, Minji
    Park, Seong-wook
    Kang, Chang Kyung
    Choe, Pyoeng Gyun
    Kim, Nam Joong
    Jo, Hyeon Jae
    Shin, Hyun Mu
    Lee, Chang-Han
    Kim, Hang-Rae
    Park, Wan Beom
    Oh, Myoung-don
    INFECTIOUS DISEASES, 2024, 56 (02) : 116 - 127
  • [39] Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico
    Dominguez-Ramirez, Lenin
    Solis-Tejeda, Itzel
    Ayon-Aguilar, Jorge
    Mayoral-Ortiz, Antonio
    Sosa-Jurado, Francisca
    Pelayo, Rosana
    Santos-Lopez, Gerardo
    Cortes-Hernandez, Paulina
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [40] Asthma and Susceptibility to COVID-19 in Australian Children During Alpha, Delta and Omicron Waves of the COVID-19 Pandemic
    Chan, Mei
    Owens, Louisa
    Gray, Melinda Louise
    Selvadurai, Hiran
    Jaffe, Adam
    Homaira, Nusrat
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1139 - 1155